(Q48245672)

9 February 2018

title

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. (English)

1 reference

9 February 2018

1 reference

4

1 reference

9 February 2018

Yehuda Shoenfeld

series ordinal

3

object named as

Y Shoenfeld

1 reference

9 February 2018

1

J Chapman

1 reference

9 February 2018

M Cohen-Armon

2

1 reference

9 February 2018

publication date

1 January 1999

1 reference

9 February 2018

published in

Lupus

1 reference

9 February 2018

volume

8

1 reference

9 February 2018

page(s)

127-133

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

cites work

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Migraine and the lupus anticoagulant. Case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Lupus anticoagulant and late onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Reversible dementia and chorea in a young woman with the lupus anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Evidence for bound antineuronal antibodies in brains of NZB/W mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: role of genotype and autoimmune disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Early onset of autoimmunity in MRL/++ mice following immunization with beta 2 glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Immunology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Inhibition of pertussis toxin catalyzed ADP-ribosylation of G-proteins by membrane depolarization in rat brain synaptoneurosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Measurement of membrane potentials (psi) of erythrocytes and white adipocytes by the accumulation of triphenylmethylphosphonium cation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Antiphospholipid antibody binding to bilayer-coated glass microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

Animal models for nervous system disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678847524

10.1191/096120399678847524

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10192507

1 reference

9 February 2018